作者：
Hodi, F. Stephen [1]
;
Chapman, Paul B. [2]
;
Sznol, Mario [3]
;
Lao, Christopher D. [4]
;
Gonzalez, Rene [5]
;
Smylie, Michael [6]
;
Daniels, Gregory A. [7]
;
Thompson, John A. [8]
;
Kudchadkar, Ragini [9]
;
Sharfman, William [10]
;
Atkins, Michael [11]
;
Spigel, David R. [12]
;
Pavlick, Anna [13]
;
Monzon, Jose [14]
;
Kim, Kevin B. [15]
;
Ernst, Scott [16]
;
Khushalani, Nikhil, I [17]
;
van Dijck, Wim [18]
;
Lobo, Maurice [19]
;
Hogg, David
作者单位：
Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA USA
[1]
London Hlth Sci Ctr, Med Oncol, London, ON, Canada
[2]
H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol, Tampa, FL USA
[3]
UC San Diego Hlth La Jolla, Med Oncol, La Jolla, CA USA
[4]
Georgetown Lombardi Comprehens Canc Ctr, Med Oncol, Washington, DC USA
[5]
Mem Sloan Kettering Canc Ctr, Med Oncol, 1275 York Ave, New York, NY 10021 USA
[6]
Tom Baker Canc Clin, Med Oncol, Calgary, AB, Canada
[7]
Cross Canc Inst, Med Oncol & Clin Res, Edmonton, AB, Canada
[8]
Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA
[9]
Univ Michigan, Dermatol, Ann Arbor, MI 48109 USA
[10]
NYU Langone, Med Oncol, Laura & Isaac Perlmutter Canc Ctr, New York, NY USA
[11]
Calif Pacific Med Ctr Res Inst, Med Oncol, San Francisco, CA USA
[12]
Tennessee Oncol PLLC, Med Oncol, Sarah Cannon Res Inst, Nashville, TN USA
[13]
Kimmel Inst Canc Immunotherapy, Cutaneous Oncol, Baltimore, MD USA
[14]
Univ Colorado, Med Oncol, Canc Ctr, Aurora, CO USA
[15]
Yale Univ, Sch Med, Med Oncol, New Haven, CT USA
[16]
Seattle Canc Care Alliance, Phase Clin Trials Program 1, Seattle, WA USA
[17]
Bristol Myers Squibb, Princeton, NJ USA
[18]
Princess Margaret Canc Ctr, Div Med Oncol & Hematol, Toronto, ON, Canada
[19]
发布时间
2021-06-09
换一批
